HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Red wine consumption is inversely associated with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adduct levels in prostate.

Abstract
In humans, genetic variation and dietary factors may alter the biological effects of exposure to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), one of the major heterocyclic amines generated from cooking meats at high temperatures that has carcinogenic potential through the formation of DNA adducts. Previously, we reported grilled red meat consumption associated with PhIP-DNA adduct levels in human prostate. In this study, we expanded our investigation to estimate the associations between beverage consumption and PhIP-DNA adduct levels in prostate for 391 prostate cancer cases. Of the 15 beverages analyzed, red wine consumption had the strongest association with PhIP-DNA adduct levels showing an inverse correlation in both tumor (P = 0.006) and nontumor (P = 0.002) prostate cells. Red wine consumption was significantly lower in African American compared with white cases, but PhIP-DNA adduct levels in prostate did not vary by race. In African Americans compared with whites, however, associations between red wine consumption and PhIP-DNA adduct levels were not as strong as associations with specific (e.g., SULT1A1 and UGT1A10 genotypes) and nonspecific (e.g., African ancestry) genetic variation. In a multivariable model, the covariate for red wine consumption explained a comparable percentage (13%-16%) of the variation in PhIP-DNA adduct levels in prostate across the two racial groups, but the aforementioned genetic factors explained 33% of the PhIP-DNA adduct variation in African American cases, whereas only 19% of the PhIP-DNA adduct variation in whites. We conclude that red wine consumption may counteract biological effects of PhIP exposure in human prostate, but genetic factors may play an even larger role, particularly in African Americans.
AuthorsBenjamin A Rybicki, Christine Neslund-Dudas, Cathryn H Bock, Nora L Nock, Andrew Rundle, Michelle Jankowski, Albert M Levin, Jennifer Beebe-Dimmer, Adnan T Savera, Satoru Takahashi, Tomoyuki Shirai, Deliang Tang
JournalCancer prevention research (Philadelphia, Pa.) (Cancer Prev Res (Phila)) Vol. 4 Issue 10 Pg. 1636-44 (Oct 2011) ISSN: 1940-6215 [Electronic] United States
PMID21846795 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • 2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct
  • DNA Adducts
  • DNA, Neoplasm
  • Imidazoles
  • bilirubin uridine-diphosphoglucuronosyl transferase 1A10
  • Glucuronosyltransferase
  • Arylsulfotransferase
  • SULT1A1 protein, human
Topics
  • Black or African American (statistics & numerical data)
  • Arylsulfotransferase (genetics)
  • DNA Adducts (metabolism)
  • DNA, Neoplasm (genetics)
  • Genotype
  • Glucuronosyltransferase (genetics)
  • Humans
  • Imidazoles (metabolism)
  • Immunoenzyme Techniques
  • Male
  • Meat (adverse effects)
  • Middle Aged
  • Odds Ratio
  • Polymerase Chain Reaction
  • Prognosis
  • Prostatic Neoplasms (ethnology, etiology, metabolism)
  • Risk Factors
  • White People (statistics & numerical data)
  • Wine (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: